Personalized medicine--trends in molecular diagnostics: exponential growth expected in the next ten years.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Diagnosis & Therapy

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/11534880-000000000-00000PMID 21469770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Personalized Medicine — Trends in Molecular Diagnosticsy

  2012cited by this paper
• Personalized medicine--trends in molecular diagnostics: exponential growth expected in the next ten years.

  2011cited by this paper

• A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery

  2022cites this paper
• Perioperative renal protection

  2021cites this paper
• Prospects for personalized rehabilitative medicine

  2021cites this paper
• Predictive Medicine

  2021cites this paper
• Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?

  2019cites this paper
• A graphene-based biosensor for detecting microRNA with augmented sensitivity through helicase-assisted signal amplification of hybridization chain reaction

  2018cites this paper
• THE REAL HORIZONS OF PERSONALIZED MEDICINE. STRATEGY AND DEVELOPMENT OPTIONS

  2017cites this paper
• [Radionuclide teranostic of malignancies].

  2016cites this paper
• Oncoproteomics: Trials and tribulations

  2016cites this paper
• Ризики лапароскопічної холецистектомії у хворих на жовчнокам’яну хворобу на тлі ішемічної хвороби серця

  2016cites this paper
• Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection

  2015cites this paper
• Pharmacogenetics, Pharmacogenomics and Ayurgenomics for Personalized Medicine: A Paradigm Shift

  2015cites this paper
• Molecular Imaging in the Era of Personalized Medicine

  2015cites this paper
• Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors

  2015cites this paper
• Physiology of Cancer: Prospective Aspects beyond the 21st Century

  2015cites this paper
• Future directions in overactive bladder treatment: Personalized medicine can be applied?

  2015cites this paper
• Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer

  2015cites this paper
• Molecular biomarkers in clinical development: what could we learn from the clinical trial registry?

  2014cites this paper
• Personalized medicine for the management of benign prostatic hyperplasia.

  2014cites this paper
• [An economic perspective on targeted treatments].

  2014cites this paper
• Perspective économique sur les traitements ciblés

  2014cites this paper
• Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine

  2014cites this paper
• Personalized Medicine in Oncology and Companion Diagnostics: Development and Challenges

  2013cites this paper
• Adresser les défis de passage à l'échelle en génomique comparée. (Adressing scaling challenges in comparative genomics)

  2013cites this paper
• Personalized oncology: recent advances and future challenges.

  2013influential citation
• Research and applications: A rational free energy-based approach to understanding and targeting disease-causing missense mutations

  2013cites this paper
• Pharmacogenomics and Personalized Medicine for Cancer

  2013cites this paper
• The Marker State Space (MSS) Method for Classifying Clinical Samples

  2013cites this paper
• Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients

  2012cites this paper
• Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine

  2012cites this paper
• Personalized Medicine — Trends in Molecular Diagnosticsy

  2012cites this paper
• How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care

  2012cites this paper
• Bridging the "Valley of Death" in stratified medicine : commercializing molecular diagnostics in oncology

  2012cites this paper
• Use of MMP‐8 and MMP‐9 to assess disease severity in children with viral lower respiratory tract infections†

  2012cites this paper
• CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection

  2012cites this paper
• Best practices for companion diagnostic and therapeutic development: translating between the stakeholders.

  2012cites this paper
• Predictive biomarkers in advance of a companion drug: ahead of their time?

  2012cites this paper
• A New Paradigm for Personalized Medicine and Companion Diagnostics: The Contract Diagnostics Organization

  2012cites this paper
• Clinical application of high throughput molecular screening techniques for pharmacogenomics

  2011cites this paper
• Clinical application of high throughput molecular screening techniques for pharmacogenomics

  2011cites this paper
• Personalized medicine--trends in molecular diagnostics: exponential growth expected in the next ten years.

  2011cites this paper